Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biosimilars: Postmarketing Data Alone Not Enough For Interchangeability

Jan 18 2017

• By Sue Sutter

Related Content

Amgen's Amjevita Approved As First Biosimilar To AbbVie's Humira

Sep 24 2016

Inflectra Label Not Exactly Silent On Remicade's Orphan-Protected Claim

Apr 06 2016

Biologic Product Naming: US FDA Sticks With Suffixes ‘Devoid Of Meaning’

Jan 13 2017

Off-Label Communication: When Does It Align With Approved Labeling?

Jan 18 2017

Related Companies

Celltrion, Inc.

Amgen, Inc.

Johnson & Johnson

AbbVie Inc.

Pelican Technology Holdings, Inc.

Additional Topics

Regulation Biosimilars Drug Approval Standards BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window